From Regional Patient Advocate Javier Santana:

I have held discussions with a pharma company from Costa Rica who wishes to introduce a generic HAE treatment to Costa Rica, Guatemala, and Peru. The company is currently engaged in discussions with doctors in these countries.

The first National Forum of Rare Diseases in Costa Rica was held on 29 February 2020. Doctors, as well as patients with rare diseases, participated in the event.